<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for EXEL</title>
    <link />
    <description>Headlines for Exelixis</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Reminder: Cabozantinib to be Featured in Nine Presentations at the 2013 ASCO Annual Meeting</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/15/reminder-cabozantinib-to-be-featured-in-nine-prese/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 15 May 2013 16:28:10 GMT</pubDate>
    </item>
    <item>
      <title>Exelixis' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1434671-exelixis-ceo-presents-at-bank-of-america-merrill-lynch-health-care-conference-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 14 May 2013 17:32:21 GMT</pubDate>
    </item>
    <item>
      <title>Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1428181-part-1-will-array-biopharma-become-a-late-stage-biopharmaceutical-company.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 12 May 2013 18:06:09 GMT</pubDate>
    </item>
    <item>
      <title>Exelixis Announces Webcasts of Upcoming Investor Conference Presentations</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/08/exelixis-announces-webcasts-of-upcoming-investor-c/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 08 May 2013 18:20:18 GMT</pubDate>
    </item>
    <item>
      <title>EXEL Crosses Above Key Moving Average Level</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11917993/1/exel-crosses-above-key-moving-average-level.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Wed, 08 May 2013 16:35:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Stocks to Get on Your Watchlist</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/08/3-stocks-to-get-on-your-watchlist-33/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 08 May 2013 13:26:00 GMT</pubDate>
    </item>
    <item>
      <title>Exelixis' CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1412361-exelixis-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 07 May 2013 23:07:04 GMT</pubDate>
    </item>
    <item>
      <title>Exelixis Announces First Quarter 2013 Financial Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/07/exelixis-announces-first-quarter-2013-financial-re/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 07 May 2013 17:50:56 GMT</pubDate>
    </item>
    <item>
      <title>Cabozantinib to be Featured in Nine Presentations at the 2013 ASCO Annual Meeting</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/07/cabozantinib-to-be-featured-in-nine-presentations-/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 07 May 2013 17:35:35 GMT</pubDate>
    </item>
    <item>
      <title>Exelixis 1st-Quarter Loss Widened as Revenue Slumps Amid Year-Earlier Impacts</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130507-000526&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Tue, 07 May 2013 16:54:59 GMT</pubDate>
    </item>
    <item>
      <title>5 Reasons to Worry About Next Week</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/03/5-reasons-to-worry-about-next-week-31/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 03 May 2013 17:15:00 GMT</pubDate>
    </item>
    <item>
      <title>Here's What This $9 Billion Contrarian Has Been Buying</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/29/heres-what-this-9-billion-contrarian-has-been-bu/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 29 Apr 2013 20:20:00 GMT</pubDate>
    </item>
    <item>
      <title>Exelixis Announces May 7th Webcast of First Quarter 2013 Financial Results Conference Call</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/17/exelixis-announces-may-7th-webcast-of-first-quarte/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 17 Apr 2013 18:34:56 GMT</pubDate>
    </item>
    <item>
      <title>'Mad Money' Lightning Round: Buy, Buy, Buy Toll Brothers</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11894564/1/mad-money-lightning-round-buy-buy-buy-toll-brothers.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Wed, 17 Apr 2013 06:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Cramer's 'Mad Money' Recap: A Rally With Some Fizz</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11894558/1/cramers-mad-money-recap-a-rally-with-some-fizz.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 16 Apr 2013 20:12:00 GMT</pubDate>
    </item>
    <item>
      <title>Preclinical Data Presented at AACR Describe a Mechanism of Action of Cabozantinib in a Prostate Canc</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/09/preclinical-data-presented-at-aacr-describe-a-mech/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 09 Apr 2013 16:21:18 GMT</pubDate>
    </item>
    <item>
      <title>Solving The R&amp;D Investment Dilemma With Project Funding: Mark Kessel</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1297051-solving-the-r-d-investment-dilemma-with-project-funding-mark-kessel.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 24 Mar 2013 04:30:20 GMT</pubDate>
    </item>
    <item>
      <title>Buy, Sell, or Hold: Exelixis</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/20/buy-sell-or-hold-exelixis/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 20 Mar 2013 14:57:00 GMT</pubDate>
    </item>
    <item>
      <title>Here's What This 220% Gainer Has Been Buying and Selling</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/18/heres-what-this-220-gainer-has-been-buying-and-s/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 18 Mar 2013 22:34:00 GMT</pubDate>
    </item>
    <item>
      <title>Tackling Cancer: Prostate Cancer's Biggest Current and Upcoming Players</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/05/tackling-cancer-prostate-cancers-biggest-current-u/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 05 Mar 2013 11:23:00 GMT</pubDate>
    </item>
  </channel>
</rss>
